Objective:Ovarian cancer is one of the leading causes of death in women,because of late diagnosis,recurrence and resistance to chemotherapy.Therefore,it's necessary to design a novel sensitive and specific maker t...Objective:Ovarian cancer is one of the leading causes of death in women,because of late diagnosis,recurrence and resistance to chemotherapy.Therefore,it's necessary to design a novel sensitive and specific maker to diagnose and treat patients of ovarian cancer.However,this study intends to explore the expression and prognostic value of ENO1 in ovarian cancer.Method:ENO1 data were collected from Oncomine database,and then were performed subgroup analysis and systematic analysis.Meanwhile,the prognostic significance of ENO1 was analyzed by an online survival analysis tool"Kaplan-Meier Plotter"(KM plotter)database.Results:In Oncomine database,a total of 14 studies were involved ENO1 in ovarian cancer tissues and normal tissues,including a total of 1001 samples.Comparing with normal tissues,ENO1 expression is higher(P<0.05).Moreover,the overall survival of ENO1 high expression in ovarian cancer is closely related with high survival(P<0.05).Further study indicated that ENO1 expression showed negative relation to the prognosis of serous ovarian cancer patients while ENO1 expression showed no effects on the prognosis of endometrioid ovarian cancer patients.Conclusion:Through exploration of tumor gene information in Oncomine database,ENO1 was found highly expressed in ovarian cancer and related to the prognosis of ovarian cancer,which might be a new marker for ovarian cancer prognosis and alternative drug therapy.展开更多
胃癌在世界范围内直接影响着人类的生活质量,癌胚抗原相关细胞粘附分子(CEACAM)亚家族的一些成员在肿瘤中不受调控。对于CEACAM8在胃癌中的功能知之甚少。为了解决这一问题,本研究使用UALCAN、Kaplan-Meier Plotter、metascape数据库研...胃癌在世界范围内直接影响着人类的生活质量,癌胚抗原相关细胞粘附分子(CEACAM)亚家族的一些成员在肿瘤中不受调控。对于CEACAM8在胃癌中的功能知之甚少。为了解决这一问题,本研究使用UALCAN、Kaplan-Meier Plotter、metascape数据库研究了CEACAM8在胃癌预后中的作用。发现CEACAM8的过表达与胃癌患者的临床肿瘤分期和病理肿瘤分级显著相关。此外,CEACAM8 mRNA的高表达与胃癌患者较短的总生存期(OS)显著相关。总的来说,CEACAM8可能是胃癌患者生存的预后生物标志物。Gastric cancer directly affects human quality of life worldwide, and some members of the carcinoembryonic antigen-associated cell adhesion molecule (CEACAM) subfamily are not regulated in tumors. Little is known about the function of CEACAM8 in gastric cancer. In order to solve this problem, this study used UALCAN, Kaplan-Meier Plotter and metascape databases to study the role of CEACAM8 in the prognosis of gastric cancer. It was found that the overexpression of CEACAM8 was significantly correlated with the clinical tumor stage and pathological tumor grade of gastric cancer patients. In addition, high expression of CEACAM8 mRNA was significantly associated with shorter overall survival (OS) in patients with gastric cancer. Overall, CEACAM8 may be a prognostic biomarker for survival in patients with gastric cancer.展开更多
目的 探讨分离酶(ESPL1)基因在卵巢癌中的表达及意义。方法 利用GEPIA数据库,对比相应正常组织,分析ESPL1在泛癌及卵巢癌中的表达。运用The Human Protein Atlas数据库,分析ESPL1蛋白在卵巢及卵巢癌组织中表达及定位;应用String数据库绘...目的 探讨分离酶(ESPL1)基因在卵巢癌中的表达及意义。方法 利用GEPIA数据库,对比相应正常组织,分析ESPL1在泛癌及卵巢癌中的表达。运用The Human Protein Atlas数据库,分析ESPL1蛋白在卵巢及卵巢癌组织中表达及定位;应用String数据库绘制ESPL1基因的相关蛋白网络图,并进行基因功能富集分析。使用Kaplan-Meier Plotter网站,对ESPL1表达影响不同临床特征患者预后指标及化疗药物疗效进行分析。结果 ESPL1在14种恶性肿瘤中表达明显上调,而在食管癌中表达量下调;与正常卵巢组织相比,在卵巢癌中ESPL1基因在mRNA及蛋白质水平的表达显著升高,在卵巢癌中表达定位于细胞膜或浆及核中。与ESPL1基因相互作用蛋白有SMC3、KIF11、PTTG1等10个,主要富集在细胞周期、卵母细胞减数分裂等信号通路。Kaplan-Meier生存分析显示,ESPL1高表达的卵巢癌患者总生存时间明显短于ESPL1低表达者,且临床I+II期患者总生存期较短(P<0.05),其它期别及病理分级的患者预后无差异;应用多西他赛单药组中,ESPL1高表达组较低表达组总生存期下降,有显著差异(P<0.05),而在铂类、紫杉醇、泰素、吉西他滨、拓扑替康单药治疗的患者中,两组间无显著性差异。结论 ESPL1基因在多种肿瘤组织及卵巢癌组织中高表达;其相互作用的网络蛋白主要富集在细胞周期信号通路;高表达ESPL1基因的卵巢癌患者预后差,特别是早期卵巢癌患者,化疗药物不宜选择多西他赛。该基因也许可作为卵巢癌预后及一线化疗药物选择潜在参考指标。展开更多
文摘Objective:Ovarian cancer is one of the leading causes of death in women,because of late diagnosis,recurrence and resistance to chemotherapy.Therefore,it's necessary to design a novel sensitive and specific maker to diagnose and treat patients of ovarian cancer.However,this study intends to explore the expression and prognostic value of ENO1 in ovarian cancer.Method:ENO1 data were collected from Oncomine database,and then were performed subgroup analysis and systematic analysis.Meanwhile,the prognostic significance of ENO1 was analyzed by an online survival analysis tool"Kaplan-Meier Plotter"(KM plotter)database.Results:In Oncomine database,a total of 14 studies were involved ENO1 in ovarian cancer tissues and normal tissues,including a total of 1001 samples.Comparing with normal tissues,ENO1 expression is higher(P<0.05).Moreover,the overall survival of ENO1 high expression in ovarian cancer is closely related with high survival(P<0.05).Further study indicated that ENO1 expression showed negative relation to the prognosis of serous ovarian cancer patients while ENO1 expression showed no effects on the prognosis of endometrioid ovarian cancer patients.Conclusion:Through exploration of tumor gene information in Oncomine database,ENO1 was found highly expressed in ovarian cancer and related to the prognosis of ovarian cancer,which might be a new marker for ovarian cancer prognosis and alternative drug therapy.
文摘胃癌在世界范围内直接影响着人类的生活质量,癌胚抗原相关细胞粘附分子(CEACAM)亚家族的一些成员在肿瘤中不受调控。对于CEACAM8在胃癌中的功能知之甚少。为了解决这一问题,本研究使用UALCAN、Kaplan-Meier Plotter、metascape数据库研究了CEACAM8在胃癌预后中的作用。发现CEACAM8的过表达与胃癌患者的临床肿瘤分期和病理肿瘤分级显著相关。此外,CEACAM8 mRNA的高表达与胃癌患者较短的总生存期(OS)显著相关。总的来说,CEACAM8可能是胃癌患者生存的预后生物标志物。Gastric cancer directly affects human quality of life worldwide, and some members of the carcinoembryonic antigen-associated cell adhesion molecule (CEACAM) subfamily are not regulated in tumors. Little is known about the function of CEACAM8 in gastric cancer. In order to solve this problem, this study used UALCAN, Kaplan-Meier Plotter and metascape databases to study the role of CEACAM8 in the prognosis of gastric cancer. It was found that the overexpression of CEACAM8 was significantly correlated with the clinical tumor stage and pathological tumor grade of gastric cancer patients. In addition, high expression of CEACAM8 mRNA was significantly associated with shorter overall survival (OS) in patients with gastric cancer. Overall, CEACAM8 may be a prognostic biomarker for survival in patients with gastric cancer.
文摘目的 探讨分离酶(ESPL1)基因在卵巢癌中的表达及意义。方法 利用GEPIA数据库,对比相应正常组织,分析ESPL1在泛癌及卵巢癌中的表达。运用The Human Protein Atlas数据库,分析ESPL1蛋白在卵巢及卵巢癌组织中表达及定位;应用String数据库绘制ESPL1基因的相关蛋白网络图,并进行基因功能富集分析。使用Kaplan-Meier Plotter网站,对ESPL1表达影响不同临床特征患者预后指标及化疗药物疗效进行分析。结果 ESPL1在14种恶性肿瘤中表达明显上调,而在食管癌中表达量下调;与正常卵巢组织相比,在卵巢癌中ESPL1基因在mRNA及蛋白质水平的表达显著升高,在卵巢癌中表达定位于细胞膜或浆及核中。与ESPL1基因相互作用蛋白有SMC3、KIF11、PTTG1等10个,主要富集在细胞周期、卵母细胞减数分裂等信号通路。Kaplan-Meier生存分析显示,ESPL1高表达的卵巢癌患者总生存时间明显短于ESPL1低表达者,且临床I+II期患者总生存期较短(P<0.05),其它期别及病理分级的患者预后无差异;应用多西他赛单药组中,ESPL1高表达组较低表达组总生存期下降,有显著差异(P<0.05),而在铂类、紫杉醇、泰素、吉西他滨、拓扑替康单药治疗的患者中,两组间无显著性差异。结论 ESPL1基因在多种肿瘤组织及卵巢癌组织中高表达;其相互作用的网络蛋白主要富集在细胞周期信号通路;高表达ESPL1基因的卵巢癌患者预后差,特别是早期卵巢癌患者,化疗药物不宜选择多西他赛。该基因也许可作为卵巢癌预后及一线化疗药物选择潜在参考指标。
